Related Experiment Video
Updated: Mar 20, 2026

13:04
Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells
Published on: May 16, 2019
39.3K
Trace Element Analyses (Zinc and Selenium) in Pediatric Malignant Lymphomas.
Summary
Children with malignant lymphomas in Turkey often have chronic zinc and selenium deficiencies, likely due to poor nutrition. Supplementation alongside standard treatment is suggested for these essential minerals.
Area of Science:
- Pediatric Oncology
- Nutritional Biochemistry
- Trace Element Research
Background:
- Malignant lymphomas are serious conditions in children.
- Nutritional status, particularly trace elements, may play a role in disease development or progression.
- Zinc and selenium are essential minerals with known roles in immune function.
Purpose of the Study:
- To investigate the zinc (Zn) and selenium (Se) status in untreated Turkish children diagnosed with malignant lymphomas.
- To determine if deficiencies in Zn and Se are associated with these cancers.
- To explore the potential impact of socioeconomic factors on nutritional status in pediatric cancer patients.
Main Methods:
- Studied 96 untreated patients: 81 with Hodgkin's disease and 15 with Burkitt's lymphoma.
- Measured plasma and hair levels of zinc (Zn) and selenium (Se) using atomic absorption spectrophotometry.
- Assessed chronic deficiencies by evaluating combined low plasma and low hair Zn and Se levels.
Main Results:
- Chronic deficiencies in both zinc and selenium were observed in children with malignant lymphomas.
- These deficiencies were associated with the presence of malignant lymphomas in the studied cohort.
- A majority of cases originated from low socioeconomic backgrounds, suggesting a link to nutritional environment.
Conclusions:
- Chronic zinc and selenium deficiencies are linked to malignant lymphomas in Turkish children.
- Poor nutritional environment, influenced by socioeconomic status, is a likely contributing factor.
- Supplementation with physiological doses of zinc and selenium is proposed as an adjunct therapy to chemo-radiotherapy.

